Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma
Johann von Felden, Henning Wege, Kornelius Schulze – 9 August 2020
Johann von Felden, Henning Wege, Kornelius Schulze – 9 August 2020
Shi Liu, Qi Huang, Bin Zhou, Haitao Guo, Jian Sun – 9 August 2020
Hao Liao, Jie Wang, Yan Liu, Junhui Chen, Dongping Xu, Fengmin Lu – 9 August 2020
Courtney B. Sherman, Adnan Said, Michael Kriss, Vishnu S. Potluri, Josh Levitsky, Peter P. Reese, Judy A. Shea, Marina Serper – 9 August 2020
Shari S. Rogal – 9 August 2020
Carla W. Brady, Jennifer B. Gilner – 9 August 2020
Gagandeep Brar, Tim F. Greten, Barry I. Graubard, Timothy S. McNeel, Jessica L. Petrick, Katherine A. McGlynn, Sean F. Altekruse – 9 August 2020 – In the United States, hepatocellular carcinoma (HCC) survival varies with tumor characteristics, patient comorbidities, and treatment. The effect of HCC etiology on survival is less clearly defined. The relationship between HCC etiology and mortality was examined using Surveillance, Epidemiology, and End Results–Medicare data.
Patricia P. Bloom, Seth A. Waits – 8 August 2020
Allison J. Kwong, Deepika Devuni, Connie Wang, Justin Boike, Jennifer Jo, Lisa VanWagner, Marina Serper, Lauren Jones, Rajani Sharma, Elizabeth C. Verna, Julia Shor, Margarita N. German, Alexander Hristov, Alexander Lee, Erin Spengler, Ayman A. Koteish, Gurbir Sehmbey, Anil Seetharam, Nimy John, Yuval Patel, Matthew R. Kappus, Thomas Couri, Sonali Paul, Reena J. Salgia, Quan Nhu, Catherine T. Frenette, Jennifer C.
Anand V. Kulkarni, Mithun Sharma, Pramod Kumar, Rajesh Gupta, Padaki Nagaraja Rao – 8 August 2020